Skip to main content

Celera Signs on Emory, Van Andel as Subscribers to Database

NEW YORK, March 30 – Celera said Friday it has signed Emory University and the Van Andel Institute as subscribers to its database, and has extended its subscription agreement with the University of Texas Southwestern Medical Center to include the University of Texas M.D. Anderson Cancer Center in Houston.

Under the multi-year subscription agreements, researchers at Emory of Atlanta, the Van Andel Institute, a basic cancer research institute in Grand Rapids, Mich., and the M.D. Anderson Cancer Center will have full access to all of Celera’s databases through the Celera Discovery system, a web-based interface that includes software tools for searching and analyzing Celera’s proprietary databases.

The cost of the subscriptions were not disclosed, but Celera generally charges academic subscribers between $7,000 and $15,000 a year per scientist using the databases.

These new agreements add to Celera's list of over 30 subscribers to its database products, including 23 whose names have been publicly announced 

Celera’s other database subscribers include the University of California system, the Max Planck Society for Advancement of Science, the Karolinska Institutet, the University of Tokyo, Pfizer, Takeda, and American Home Products. 

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.